The Times Australia
Google AI
The Times World News

.

Western pharma companies should supply only essential medicines to Russia

  • Written by Alex Polyakov, Clinical Associate Professor, Faculty of Medicine, Dentistry & Health Sciences., The University of Melbourne
Western pharma companies should supply only essential medicines to Russia

In response to Russia’s invasion of Ukraine and overwhelming destruction of property and loss of innocent lives, a number of western companies – from McDonalds to Apple[1] – stopped or severely limited their activities in the Russian Federation.

One glaring exception appears to be the majority of western pharmaceutical companies that continue to supply medicines and equipment.

There is growing political and consumer pressure on these companies to take steps to join the concerted efforts designed to pressure the Russian government to stop the war in Ukraine.

The counterargument[2] advanced by the companies continuing business in Russia revolves around the fact medicines are exempt from sanctions on humanitarian grounds.

However there is a way pharmaceutical companies could signal their disapproval to Russia, without risking the lives of ordinary Russian citizens.

Read more: What are sanctions, do they ever work – and could they stop Russia's invasion of Ukraine?[3]

Separate the people from Putin

Western countries that imposed crippling sanctions on the Russian economy are not technically at war with Russia. Therefore, unless directed by their governments as part of the sanctions regime, these companies have no legal barriers to continuing to supply medicines to Russia.

Emergency services workers searching through rubble.
All western companies should be participating in the effort to condemn the Russian government for their actions. AAP/Andrezej Lange

It is also true that any interruption in the supply of medicines will disproportionately affect the most disadvantaged members of the Russian society, while having minimal impact on the country’s elite and decision-makers.

Furthermore, one could legitimately argue the majority of the Russian people are not responsible for the decisions made at the top and should not suffer unjustly. It is also likely the current government of Russia may not be swayed by the suffering of its people and therefore any interruption of supply of medicines may create human misery without any appreciable gain.

Still, there is little doubt widespread abandonment of Russia by western companies will have a substantial impact on the Russian government, economy and population. Therefore, it is morally essential for western drug companies to take some concrete steps to participate in the effort to influence the Russian government as well as its people.

Read more: The power of tech giants has made them as influential as nations. Here's how they're sanctioning Russia[4]

Some pharma companies are withdrawing

A list of companies[5] that either withdrew, scaled back or continue to operate in Russia demonstrates the majority of pharmaceutical companies have either scaled back their involvement in the Russian economy or continue to operate at pre-war levels.

Those that scaled back have done so to a variable extent, in some instances only reducing their activity by a tokenistic amount, such as suspending advertising in Russia, delaying new investments or pausing clinical trial enrolments.

People walk through Red Square in Moscow. Innocent Russian citizens should still have access to life saving medicines. Yuri Kotchetkov/AAP[6]

These minimalistic measures are unlikely to have a meaningful impact and are likewise unlikely to be acceptable by the general public in the west or by activist shareholders. Some companies appear to have taken no steps to reduce their activities in Russia and appear at the very bottom of the list.

Western pharmaceutical companies must balance two conflicting considerations: they must provide life-saving medicines to avoid humanitarian disaster in Russia, and at the same time they must not appear to support in any way the humanitarian catastrophe currently taking place in Ukraine.

Read more: Can a martini stop Putin? How consumers and investors are imposing DIY sanctions on Russia[7]

What should pharmaceutical companies do?

It is a difficult line to tread, however there is a pragmatic compromise. Essential medicines, as defined by the World Health Organisation’s Expert Committee on Selection and Use of Essential Medicines[8], could continue to be supplied, with all other business ceasing.

Medicines on this essential list are defined as:

those that satisfy the priority health care needs of the population. They are intended to be available within the context of function health systems at all times, in adequate amounts, in the appropriate dosage forms, of assured quality and at prices that individuals and the community can afford.

This would include medicines for serious chronic illness, life-saving cancer drugs, antibiotics, antivirals, poison antidotes, and pain relief and anaesthetics.

Western pharmaceutical companies should only supply medicines in this list to Russia and suspend all other commercial activities including local manufacturing of medicines, advertising, clinical trials, scientific collaborations and infrastructure investments. Medicines not included on the essentials list should be withheld, which include drugs for non-life threatening complaints such as acne, erectile dysfunction, cosmetic medications and fertility drugs.

This action would be consistent with both their humanitarian obligations towards Russian patients and their obligations as global citizens.

Any profits derived from business activities in Russia could be considered tainted by the actions of the Russian government. Pharmaceutical companies that continue to supply essential medicines to the Russian market should consider donating profits generated by such transactions to established charities closely involved in managing the devastating humanitarian effects of Russia’s invasion of Ukraine, such as the UNICEF Ukraine Emergency Appeal[9].

Read more https://theconversation.com/western-pharma-companies-should-supply-only-essential-medicines-to-russia-179658

Times Magazine

AI is failing ‘Humanity’s Last Exam’. So what does that mean for machine intelligence?

How do you translate ancient Palmyrene script from a Roman tombstone? How many paired tendons ...

Does Cloud Accounting Provide Adequate Security for Australian Businesses?

Today, many Australian businesses rely on cloud accounting platforms to manage their finances. Bec...

Freak Weather Spikes ‘Allergic Disease’ and Eczema As Temperatures Dip

“Allergic disease” and eczema cases are spiking due to the current freak weather as the Bureau o...

IPECS Phone System in 2026: The Future of Smart Business Communication

By 2026, business communication is no longer just about making and receiving calls. It’s about speed...

With Nvidia’s second-best AI chips headed for China, the US shifts priorities from security to trade

This week, US President Donald Trump approved previously banned exports[1] of Nvidia’s powerful ...

Navman MiVue™ True 4K PRO Surround honest review

If you drive a car, you should have a dashcam. Need convincing? All I ask that you do is search fo...

The Times Features

What’s behind the surge in the price of gold and silver?

Gold and silver don’t usually move like meme stocks. They grind. They trend. They react to inflati...

State of Play: Nationals vs Liberals

The State of Play with the National Party and How Things Stand with the Liberal Party Australia’s...

SMEs face growing payroll challenges one year in on wage theft reforms

A year after wage theft reforms came into effect, Australian SMEs are confronting a new reality. P...

Evil Ray declares war on the sun

Australia's boldest sunscreen brand Australians love the sun. The sun doesn't love them back. Mela...

Resolutions for Renovations? What to do before renovating in 2026

Rolling into the New Year means many Aussies have fresh plans for their homes with renovat...

Designing an Eco Conscious Kitchen That Lasts

Sustainable kitchens are no longer a passing trend in Australia. They reflect a growing shift towa...

Why Sydney Entrepreneur Aleesha Naxakis is Trading the Boardroom for a Purpose-Driven Crown

Roselands local Aleesha Naxakis is on a mission to prove that life is a gift...

New Year, New Keys: 2026 Strategies for First Home Buyers

We are already over midway through January, and if 2025 was anything to go by, this year will be o...

How to get managers to say yes to flexible work arrangements, according to new research

In the modern workplace, flexible arrangements can be as important as salary[1] for some. For ma...